These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35046371)

  • 1. [A Case of Superior Vena Cava Syndrome Due to Recurrent Breast Cancer Effectively Treated by Trastuzumab Deruxtecan].
    Hoshino M; Ogura N; Hayashi T; Sakai G; Machino C; Oikawa H; Satou T; Hirose S; Funakoshi S
    Gan To Kagaku Ryoho; 2022 Jan; 49(1):88-90. PubMed ID: 35046371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trastuzumab deruxtecan in previously treated HER2-positive metastatic breast cancer: Plain language summary of the DESTINY-Breast01 study.
    Modi S
    Future Oncol; 2021 Sep; 17(26):3415-3423. PubMed ID: 34263665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ado-Trastuzumab Emtansine and Fam-Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring HER2 Amplification and the L755S Mutation.
    Mukohara T; Hosono A; Mimaki S; Nakayama A; Kusuhara S; Funasaka C; Nakao T; Fukasawa Y; Kondoh C; Harano K; Naito Y; Matsubara N; Tsuchihara K; Kuwata T
    Oncologist; 2021 Aug; 26(8):635-639. PubMed ID: 33559918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study.
    Modi S; Park H; Murthy RK; Iwata H; Tamura K; Tsurutani J; Moreno-Aspitia A; Doi T; Sagara Y; Redfern C; Krop IE; Lee C; Fujisaki Y; Sugihara M; Zhang L; Shahidi J; Takahashi S
    J Clin Oncol; 2020 Jun; 38(17):1887-1896. PubMed ID: 32058843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hilar lymph node metastasis of breast cancer induced bronchopleural fistula and superior vena cava syndrome.
    Nishinari Y; Kashiwaba M; Umemura A; Komatsu H; Sasaki A; Wakabayashi G
    Am J Case Rep; 2014 Nov; 15():492-5. PubMed ID: 25399335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case in Which Re-Administration of Pertuzumab/Trastuzumab with Eribulin Therapy Was Useful for Recurrent HER2 Breast Cancer].
    Kouhashi R; Kashiwagi S; Kawano Y; Yabumoto A; Ishihara S; Goto W; Asano Y; Tauchi Y; Morisaki T; Noda S; Takashima T; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2230-2232. PubMed ID: 33468917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan.
    Yin O; Iwata H; Lin CC; Tamura K; Watanabe J; Wada R; Kastrissios H; AbuTarif M; Garimella T; Lee C; Zhang L; Shahidi J; LaCreta F
    Clin Pharmacol Ther; 2021 Oct; 110(4):986-996. PubMed ID: 33999422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case of Advanced Breast Cancer in Which Marked Improvement of Joint Pain Was Obtained with Stepwise Dose Reduction of Trastuzumab Emtansine (T-DM1)].
    Yabe N; Murai S; Harada Y; Yokose T; Yokoe T; Oto I; Yoshikawa T; Kitasato K; Shimizu H; Jinno H; Kitagawa Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1818-20. PubMed ID: 26805183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
    Tamura K; Tsurutani J; Takahashi S; Iwata H; Krop IE; Redfern C; Sagara Y; Doi T; Park H; Murthy RK; Redman RA; Jikoh T; Lee C; Sugihara M; Shahidi J; Yver A; Modi S
    Lancet Oncol; 2019 Jun; 20(6):816-826. PubMed ID: 31047803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Superior vena cava syndrome successfully controlled by metallic stent insertion].
    Sakaguchi Y; Kono T; Terada Y; Noda H
    Kyobu Geka; 2009 Jun; 62(6):460-3. PubMed ID: 19522205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
    Modi S; Saura C; Yamashita T; Park YH; Kim SB; Tamura K; Andre F; Iwata H; Ito Y; Tsurutani J; Sohn J; Denduluri N; Perrin C; Aogi K; Tokunaga E; Im SA; Lee KS; Hurvitz SA; Cortes J; Lee C; Chen S; Zhang L; Shahidi J; Yver A; Krop I;
    N Engl J Med; 2020 Feb; 382(7):610-621. PubMed ID: 31825192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior vena cava syndrome caused by an intravascular thrombosis due to underlying prostate carcinoma.
    Takeda T; Saitoh M; Takeda S
    Intern Med; 2008; 47(22):2007-9. PubMed ID: 19015618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Breast Cancer Recurrence Responding to Trastuzumab Deruxtecan for Increased Cervical Lymph Node Metastasis during Anti-HER2 Therapy].
    Yamaguchi Y; Yamashiro Y; Tamura S; Hirooka K
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1267-1269. PubMed ID: 36412034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior vena cava obstruction: is stenting necessary?
    Marcy PY; Magné N; Bentolila F; Drouillard J; Bruneton JN; Descamps B
    Support Care Cancer; 2001 Mar; 9(2):103-7. PubMed ID: 11305067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab Deruxtecan Is Effective in HER2-Low Breast Cancer.
    Cancer Discov; 2020 Apr; 10(4):488. PubMed ID: 32111601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic Response to Trastuzumab Deruxtecan Rechallenge in a Patient with HER2-Positive Gastric Cancer: A Case Report.
    Ogata T; Fujita Y; Muro K
    Am J Case Rep; 2022 Mar; 23():e935600. PubMed ID: 35241641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Superior vena cava thrombosis or stricture secondary to implanted central venous access: Six cases of endovascular and direct surgical treatment in cancer patients].
    Fichelle JM; Baissas V; Salvi S; Fabiani JN
    J Med Vasc; 2018 Feb; 43(1):20-28. PubMed ID: 29425537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors.
    Indini A; Rijavec E; Grossi F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior vena cava syndrome caused by colon adenocarcinoma metastasis: a case report and review of literature.
    Bockorny M; Kourelis T; Bockorny B
    Conn Med; 2012 Feb; 76(2):77-80. PubMed ID: 22670356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985).
    Xu Z; Guo D; Jiang Z; Tong R; Jiang P; Bai L; Chen L; Zhu Y; Guo C; Shi J; Yu D
    Eur J Med Chem; 2019 Dec; 183():111682. PubMed ID: 31563805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.